XML 156 R133.htm IDEA: XBRL DOCUMENT v3.24.0.1
Employee Compensation and Benefit Plans - Schedule of Stock Unit Activity (Footnote) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock Units Reclassified From Liability-Classified Awards   436    
Chief Executive Officer        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Granted (in shares) 168,950 147,058 115,173  
Stock Units        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Granted (in shares) 421,074 373,614 236,593  
Intrinsic value of stock units vested $ 6.5 $ 2.2 $ 2.1  
Total intrinsic value of stock units vested $ 4.3 $ 2.5 $ 2.4  
Unvested stock units (in shares) 756,938 603,889 416,226 261,647
Weighted average remaining contractual term of share units outstanding (years) 1 year 8 months 12 days      
Market-based Stock Awards        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Unvested stock units (in shares) 478,263      
Net aggregate intrinsic value of stock awards outstanding $ 8.6      
Equity-Settled Awards        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Granted (in shares)   57,187    
Performance Shares        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Granted (in shares) 89,664      
Share-Based Payments Arrangement, Tranche Five | Market-based Stock Awards        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock units with market condition not met, number 396,507      
Over Three Years | Equity-Settled Awards        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Granted (in shares)   5,641    
Over Four Years | Equity-Settled Awards        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Granted (in shares)   51,546